drugset / Trial / NCT05411978
Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a multi-center, prospective, double-blind randomized controlled trial on a sample of patients with migraine. Subjects will only be enrolled when a physician or research assistant who is familiar with the study protocol is available to enroll patients. Written, informed consent will be obtained from each patient. Consent will include a discussion of the risks and benefits.
Timeline
- Start
- 2022-05-09
- Primary completion
- 2024-06-20
- Completion
- 2024-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Idebenone | Small molecule | 30 mg | Oral |
| Comparator | Idebenone | Small molecule | 90 mg | Oral |